Resumo

BELTRAN, Diego  e  MONTOYA, Mario. Hyponatremia by oxcarbacepin in multiple sclerosis, a case to take account. Rev. colom. nefrol. [online]. 2017, vol.4, n.2, pp.226-231. ISSN 2500-5006.  https://doi.org/10.22265/acnef.4.2.248.

Hyponatremia is one of the adverse effects in patients treated with oxcarbazepine. This can be seen masked by multiple symptoms which are simply attributable to other diseases, but we must always keep it in mind in a patient with a history of taking that medication. Many of patients are asymptomatic; Doses lower than 120 mmol/L show symptoms of severity which presented a patient with multiple sclerosis, which we will show below, so that diagnostic ability of clinicians plays a fundamental role.

This is why the case is exposed in which a woman treated with oxcarbazepine for one of the clinical forms of multiple sclerosis, arrives at emergency departament with manifestations of this electrolytic disorder. For this reason, the clinical case served by the authors is chosen directly.

It is concluded that this adverse reaction is not uncommon and that it must be taken into account in the differential diagnosis.

Palavras-chave : Hyponatremia; sodium; carbamacepine; multiple sclerosis; effects; paresthesia; oxcarbazepine.

        · resumo em Espanhol     · texto em Inglês | Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )